Cowen Remains Bullish on Teladoc (TDOC) Following Recent Share Weakness

Cowen reiterated an Outperform rating and $39.00 price target on Teladoc (NYSE: TDOC) as recent weakness creates a buying opportunity. As shares of TDOC have been under pressure, analyst Charles Rhyee believes the company provides a differentiated service at scale that is not easily replicated.

Rhyee commented, "Shares of TDOC have been under significant pressure the last couple days. However, after speaking with management we reiterate our view that TDOC stands at the fore of our changing health care delivery model. We strongly believe TDOC provides a differentiated service at scale, which is not easily replicated, and that the pullback in shares represents a very attractive entry point for investors."

For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.

Shares of Teladoc closed at $22.85 yesterday.

You May Also Be Interested In

• CSX (CSX) PT Raised to $46 at TD Cowen
• Expand Energy (EXE) PT Lowered to $127 at UBS
• TD Cowen Reiterates Buy Rating on Micron Technology (MU)